Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP511317.RAp86Ky5TCF_xYnm2C0oABtmJ2KgD8bE9cUxRM7mJG8nU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP511317.RAp86Ky5TCF_xYnm2C0oABtmJ2KgD8bE9cUxRM7mJG8nU130_assertion type Assertion NP511317.RAp86Ky5TCF_xYnm2C0oABtmJ2KgD8bE9cUxRM7mJG8nU130_head.
- NP511317.RAp86Ky5TCF_xYnm2C0oABtmJ2KgD8bE9cUxRM7mJG8nU130_assertion description "[The human calcium-binding protein (hS100A15) was first identified in inflamed hyperplastic psoriatic skin, where the S100A15 gene is transcribed into two mRNA splice variants, hS100A15-S and hS100A15-L. To compare the contribution of the human S100A15 (hS100A15) isoforms in skin inflammation and differentiation, we determined the expression, distribution and regulation of hS100A15-S and hS100A15-L in psoriasis and chronic atopic eczema compared with normal skin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP511317.RAp86Ky5TCF_xYnm2C0oABtmJ2KgD8bE9cUxRM7mJG8nU130_provenance.
- NP511317.RAp86Ky5TCF_xYnm2C0oABtmJ2KgD8bE9cUxRM7mJG8nU130_assertion evidence source_evidence_literature NP511317.RAp86Ky5TCF_xYnm2C0oABtmJ2KgD8bE9cUxRM7mJG8nU130_provenance.
- NP511317.RAp86Ky5TCF_xYnm2C0oABtmJ2KgD8bE9cUxRM7mJG8nU130_assertion SIO_000772 17620096 NP511317.RAp86Ky5TCF_xYnm2C0oABtmJ2KgD8bE9cUxRM7mJG8nU130_provenance.
- NP511317.RAp86Ky5TCF_xYnm2C0oABtmJ2KgD8bE9cUxRM7mJG8nU130_assertion wasDerivedFrom befree-20140225 NP511317.RAp86Ky5TCF_xYnm2C0oABtmJ2KgD8bE9cUxRM7mJG8nU130_provenance.
- NP511317.RAp86Ky5TCF_xYnm2C0oABtmJ2KgD8bE9cUxRM7mJG8nU130_assertion wasGeneratedBy ECO_0000203 NP511317.RAp86Ky5TCF_xYnm2C0oABtmJ2KgD8bE9cUxRM7mJG8nU130_provenance.